WebJul 27, 2024 · ALISO VIEJO, Calif. (PR) July 27, 2024 RARE-X announced today that Charlene Son Rigby has been appointed CEO of the rare disease technology nonprofit. An experienced business leader, Charlene Son Rigby will oversee the strategic growth of RARE-X, as well as day-to-day management. WebMar 24, 2024 · Charlene Son Rigby, B.A., M.B.A. RARE-X Aliso Viejo, CA. Ms. Rigby is the chief executive officer of RARE-X. She has spent her career building organizations at …
RARE-X Appoints Charlene Son Rigby as Chief Executive …
WebCharlene Son Rigby 6d Report this post Thrilled to announce that Global Genesand RARE-Xare merging. Together we will be able to drive more impact for rare disease patients … WebEberechukwu Onukwugha, PhD, MS University of Maryland, School of Pharmacy FULL BIO Jacob Quinton, MD, MSHS, FACP Center for Medicare and Medicaid Innovation FULL BIO Charlene Son Rigby, MBA Global Genes FULL BIO Bonnie Swenor, PhD, MPH Johns Hopkins Bloomberg School of Public Health FULL BIO Ashley Valentine, MRes Sick … ddbhealth.com
Global Genes CEO on Next-Gen Advocacy - Future of Personal …
WebApr 4, 2024 · Momentum Health Strategies. Jan 2013 - Present10 years 4 months. Alexandria, Virginia. Momentum Health Strategies provides … WebCharlene Son Rigby, B.A., M.B.A. Ms. Rigby is the chief executive officer of RARE-X. She has spent her career building organizations at the intersection of data, technology, and … WebJul 6, 2024 · During the past year, the organization named bioinformatics executive and patient advocate Charlene Son Rigby as CEO, forged a series of critical partnerships, and established a corporate advisory council including 12 leading rare disease drug developers. ddb health internships